These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30877775)

  • 1. Aspirin Triggered Resolvin D1 reduces inflammation and restores saliva secretion in a Sjögren's syndrome mouse model.
    Dean S; Wang CS; Nam K; Maruyama CL; Trump BG; Baker OJ
    Rheumatology (Oxford); 2019 Jul; 58(7):1285-1292. PubMed ID: 30877775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive modeling of aspirin-triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome.
    Yellepeddi VK; Baker OJ
    Clin Exp Dent Res; 2020 Apr; 6(2):225-235. PubMed ID: 32250566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjögren's syndrome mouse model.
    Parashar K; Schulte F; Hardt M; Baker OJ
    FASEB J; 2020 Jun; 34(6):7733-7744. PubMed ID: 32277856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice.
    Wang CS; Maruyama CL; Easley JT; Trump BG; Baker OJ
    Sci Rep; 2017 Mar; 7():45525. PubMed ID: 28361884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epithelium.
    Easley JT; Maruyama CL; Wang CS; Baker OJ
    Physiol Rep; 2016 Oct; 4(19):. PubMed ID: 27694530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specialized pro-resolving receptors are expressed in salivary glands with Sjögren's syndrome.
    Dos Santos HT; Nam K; Maslow F; Trump B; Baker OJ
    Ann Diagn Pathol; 2022 Feb; 56():151865. PubMed ID: 34847389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of resolvin D1 biosynthetic pathways in salivary epithelium.
    Leigh NJ; Nelson JW; Mellas RE; Aguirre A; Baker OJ
    J Dent Res; 2014 Mar; 93(3):300-5. PubMed ID: 24389810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin-Triggered Resolvin D1 Versus Dexamethasone in the Treatment of Sjögren's Syndrome-Like NOD/ShiLtJ Mice - A Pilot Study.
    Easley JT; Nelson JW; Mellas RE; Sommakia S; Wu C; Trump B; Baker OJ
    J Rheum Dis Treat; 2015; 1(4):. PubMed ID: 27110599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bufotalin ameliorates experimental Sjögren's syndrome development by inhibiting Th17 generation.
    Huang Y; Yang G; Fei J; Wu Y; Yan J
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Oct; 393(10):1977-1985. PubMed ID: 31950221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination treatment of low-dose dexamethasone and aspirin-triggered resolvin D1 reduces Sjögren syndrome-like features in a mouse model.
    Dos Santos HT; Maslow F; Nam K; Trump B; Weisman GA; Baker OJ
    JADA Found Sci; 2023; 2():. PubMed ID: 37622089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands.
    Nelson JW; Leigh NJ; Mellas RE; McCall AD; Aguirre A; Baker OJ
    Am J Physiol Cell Physiol; 2014 Jan; 306(2):C178-85. PubMed ID: 24259417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically-Based Pharmacokinetic Modeling.
    Yellepeddi VK; Parashar K; Dean SM; Watt KM; Constance JE; Baker OJ
    Clin Transl Sci; 2021 Mar; 14(2):683-691. PubMed ID: 33202089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current experimental methods to investigate the impact of specialized pro-resolving lipid mediators on Sjögren's syndrome.
    Dos Santos HT; Nam K; Gil D; Yellepeddi V; Baker OJ
    Front Immunol; 2022; 13():1094278. PubMed ID: 36713415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
    Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
    Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunohistochemistry-based study on aquaporin (AQP)-1, 3, 4, 5 and 8 in the parotid glands, submandibular glands and sublingual glands of Sjögren's syndrome mouse models chronically administered cevimeline.
    Nakamura M; Saga T; Watanabe K; Takahashi N; Tabira Y; Kusukawa J; Yamaki K
    Kurume Med J; 2013; 60(1):7-19. PubMed ID: 23925155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.
    Jonsson MV; Delaleu N; Brokstad KA; Berggreen E; Skarstein K
    Arthritis Rheum; 2006 Jul; 54(7):2300-5. PubMed ID: 16802370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren's Syndrome-Like Disease.
    Abughanam G; Elkashty OA; Liu Y; Bakkar MO; Tran SD
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.
    Nguyen CQ; Hu MH; Li Y; Stewart C; Peck AB
    Arthritis Rheum; 2008 Mar; 58(3):734-43. PubMed ID: 18311793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation.
    Odusanwo O; Chinthamani S; McCall A; Duffey ME; Baker OJ
    Am J Physiol Cell Physiol; 2012 May; 302(9):C1331-45. PubMed ID: 22237406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of endothelial barrier function is linked with hyposecretion and lymphocytic infiltration in salivary glands of Sjögren's syndrome.
    Cong X; Zhang XM; Zhang Y; Wei T; He QH; Zhang LW; Hua H; Lee SW; Park K; Yu GY; Wu LL
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3154-3163. PubMed ID: 29981359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.